XGN
USDExagen Inc. Common Stock
Preço em tempo real
Gráfico de preços
Métricas-chave
Métricas de mercado
Abertura
$11.080
Máximo
$11.500
Mínimo
$10.500
Volume
1.42M
Fundamentos da empresa
Capitalização de mercado
237.0M
Setor
Diagnostics & Research
País
United States
Estatísticas de negociação
Volume médio
0.23M
Bolsa de valores
NGM
Moeda
USD
Faixa de 52 semanas
Notícias relacionadas
BTIG Maintains Buy on Exagen, Raises Price Target to $15
BTIG analyst Mark Massaro maintains Exagen with a Buy and raises the price target from $13 to $15.
Exagen Inc. Reports Strong Q3 2025 Results
CARLSBAD, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (NASDAQ:XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended September 30, 2025, and recent
Canaccord Genuity Maintains Buy on Exagen, Raises Price Target to $15
Canaccord Genuity analyst Kyle Mikson maintains Exagen with a Buy and raises the price target from $11 to $15.
Exagen Announces Acceptance of Six Abstracts at 2025 American College of Rheumatology Convergence
CARLSBAD, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (NASDAQ:XGN), a leading provider of autoimmune testing, announced today the acceptance of six abstracts at the 2025 American College of Rheumatology's
BTIG Maintains Buy on Exagen, Raises Price Target to $13
BTIG analyst Mark Massaro maintains Exagen with a Buy and raises the price target from $11 to $13.
Exagen Inc. to Announce Third Quarter 2025 Financial Results on November 4, 2025
CARLSBAD, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (NASDAQ:XGN), a leading provider of innovative autoimmune testing, will release financial results for the quarter ended September 30, 2025, before the
Ações relacionadas
Mantenha-se atualizado
Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.